Long Position on CBM @ $51.25 on 12/17/2015 (Momentum)

Cambrex Corporation (CBM) is a life sciences company.

The firm provides various products and services for the development and commercialization of new and generic therapeutics worldwide.

The company’s products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products. It serves generic drug companies, and companies that discover and commercialize small molecule human therapeutics.

The company sells its products directly, as well as through independent agents.

This stock is a favorite of us and the shallow bullish "cup and handle" points to higher share prices. 

52-Weeks Trading Range: $21.12 - $55.60

Entry Point: $51.25

Stop Loss: $48.65

Target Price: $56.38

Updates

1/27/2016 12:28:39 PM

CBM closed at $38.00

Position closed on 1/27/2016 at price of $38.00 with a -25.85% loss in 41 days.

Back to Portfolio